BackInnovation1 Biotech Overview

Innovation1 Biotech Selling, General & Admin

Explore Innovation1 Biotech's selling, general & admin with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$150023.00
↓ 41.4% YoY

As of Feb 29, 2024

Annual SG&A Expenses (TTM)

$687354.00
↓ 67.45% YoY

Trailing 12 months ending Feb 29, 2024

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Innovation1 Biotech (IVBT) FAQ

Stockcircle tracks selling, general & admin for Innovation1 Biotech (IVBT), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for Innovation1 Biotech's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main IVBT overview so you can move from this figure to the surrounding analysis quickly.